Urge your members of Congress to support continued medical research funding
Updated on: August 02, 2019
continues to work with Congress, federal agencies, and other stakeholders to
ensure continued access to safe and effective hematologic drugs.
National Shortage of Intravenous Immune Globulin (IVIG)
ASH members are concerned about the national shortage of intravenous immune globulin (IVIG). The Society has contacted the U.S. Food and Drug Administration’s (FDA) Drug Shortage Office and Office of Compliance and Biologics Quality regarding the critical nature of this shortage. The FDA is directing all questions to individual manufacturers to resolve the shortage; Manufacturers’ contact information can be found online. ASH continues to monitor this shortage, and ASH members who are dealing with a critical case that requires this therapy and are encountering access issues should contact Policy and Practice Coordinator, Katherine Stark
For more information or to notify ASH of drug recalls or shortages, please contact Katherine Stark at email@example.com.
Blood: How I Treat Hematology 2017 ASH Academy ASH On Demand
Find educational and scientific meeting opportunities for hematology professionals worldwide.
Explore two interactive CML cases through an immersive simulated learning experience.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology